The Royal develops a ‘trust’ framework for AI
November 18, 2020
OTTAWA – The Royal, one of Canada’s foremost mental healthcare, teaching and research hospitals, is working in partnership with NuEnergy.ai to design a framework that uses trust as a key principle in the development of Artificial Intelligence (AI) innovations. As The Royal advances its research and technologies, a governance framework can ensure privacy, awareness of bias, ethics and transparency are upheld to support the mental health needs of clients, families and communities.
Read More
BURNABY, BC – LifeScan, a world leader in blood glucose monitoring and maker of the OneTouch brand, has announced a partnership with Shoppers Drug Mart Inc., one of Canada’s leading providers of pharmacy products and services, to pilot the retailer’s first digital diabetes management program.
MONTREAL – Aifred Health announced that it has received a $242,500 grant from MEDTEQ+, an agency that promotes economic development and innovation in medical technologies. Aifred delivers doctor-focused solutions for the treatment of mental health, including electronic access to best practices guidelines.
WATERLOO, Ont. – Technology developed by engineering researchers at the University of Waterloo has been adopted by a major pathology facility in the United States. The Joint Pathology Center (JPC), which has the world’s largest collection of preserved human tissue samples, will use an artificial intelligence search engine to index and search its digital archive as part of a modernization effort.
TORONTO – International scientists are challenging their colleagues to make Artificial Intelligence (AI) research more open and reproducible to accelerate the impact of their findings for cancer patients. In particular, they’re targeting studies that claim AI systems are better at diagnosing disease than physicians, but which fail to offer enough transparency to test and reproduce the results.
TORONTO – Hospital Intensive Care Units (ICUs) cater to patients with severe illnesses requiring constant monitoring and specialized treatment, including ventilation. Pandemics like COVID-19 significantly increase the risk of ICU overcrowding given the surge in patients, which can negatively impact the quality of care. As a result, an early understanding of a patient’s unique treatment journey, including their ICU requirements, is critical to improved treatment and better management of ICUs.
TORONTO – A team of healthcare professionals, led by Dr. Bo Wang (pictured), artificial intelligence (AI) lead at the Peter Munk Cardiac Centre, have designed an innovative tool which enables researchers to track changes in the genetic structure of the SARS-CoV-2 virus, responsible for the onset of the COVID-19 global pandemic.
LONDON, ON – Researchers at Lawson Health Research Institute are investigating whether an artificial neural network could be used to diagnose COVID-19. The AI system is being trained to learn and recognize patterns in ultrasound lung scans of patients with confirmed COVID-19 at London Health Sciences Centre (LHSC) by comparing them to ultrasound scans of patients with other types of lung infections.
MONTREAL – Faced with the urgency posed by COVID-19, Scale AI recently launched a call for projects that can help Canada meet this challenge by leveraging technology and artificial intelligence (AI). The challenge resulted in more than 120 projects being submitted in just three weeks. Eight of these projects have already passed all the stages of analysis and approval, and are being announced today, representing a total investment of over $3.4M.